Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression

International Journal of Cancer

Volumn 127, Issue 9, 2010, Pages 2230-2237

  Wu, Rong ^a,b,c   Abramson, Allan L ^a,b,c   Symons, Marc H ^a,c,d   Steinberg, Bettie M ^a,b,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

COX 2; HPV; Pak1; Pak2; Rac1; respiratory papillomas

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; P21 ACTIVATED KINASE 1; P21 ACTIVATED KINASE 2; RAC1 PROTEIN; SMALL INTERFERING RNA; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN; PAK2 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG TUMOR; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECURRENT RESPIRATORY PAPILLOMA; TUMOR CELL; CELL CULTURE; HUMAN PAPILLOMAVIRUS TYPE 11; METABOLISM; PAPILLOMAVIRUS INFECTION; RECURRENT DISEASE; SIGNAL TRANSDUCTION; VIROLOGY;

CELLS, CULTURED; CYCLOOXYGENASE 2; ENZYME ACTIVATION; HUMAN PAPILLOMAVIRUS 11; HUMANS; LUNG NEOPLASMS; P21-ACTIVATED KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; RAC1 GTP-BINDING PROTEIN; RECURRENCE; SIGNAL TRANSDUCTION;

EID: 77956640958     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25226     Document Type: Article

References (34)

1. Mounts P, Shah KV, Kashima H,. Viral etiology of juvenile-and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 1982; 79: 5425 -9.
2. Gissman L, Diehl B, Schults-Coulon J, zur Hausen H,. Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J Virol 1982; 44: 393 -9.
3. Monk BJ, Tewari KS,. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol 2007; 107: S6 -S13.
4. Vambutas A, Di Lorenzo TP, Steinberg BM,. Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res 1993; 53: 910 -14.
5. Johnston D, Hall H, Dilorenzo TP, Steinberg BM,. Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Res 1999; 59: 968 -74.
6. Zhang P, Steinberg BM,. Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Res 2000; 60: 1457 -62.
7. Sun S, Steinberg BM,. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol 2002; 83: 1651 -8.
8. Wu R, Sun S, Steinberg BM,. Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol Med 2003; 9: 77 -84.
9. Wu R, Coniglio SJ, Chan A, Symons MH, Steinberg BM,. Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas. Mol Med 2007; 13: 143 -50.
10. Vancurova I, Wu R, Miskolci V, Sun S,. Increased p50/p50 NF-kappaB activation in human papillomavirus type 6-or type 11-induced laryngeal papilloma tissue. J Virol 2002; 76: 1533 -6.
11. Wu R, Abramson AL, Shikowitz MJ, Dannenberg AJ, Steinberg BM,. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Clin Cancer Res 2005; 11: 6155 -61.
12. Tanabe T, Tohnai N,. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002; 68/69: 95 -114.
13. Thornburg NJ, Pathmanathan R, Raab-Traub N,. Activation of nuclear factor-°B p50 homodimer/Bcl3 complexes in nasopharyngeal carcinoma. Cancer Res 2003; 63: 8293 -301.
14. Farley JH, Truong V, Goo E, Uyehara C, Belnap C, Larsen WI,. A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia. Gynecol Oncol 2006; 103: 425 -30.
15. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L,. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994; 367: 40 -6.
16. Jaffer ZM, Chernoff J,. p21-activated kinases: three more join the Pak. Int J Biochem Biol 2002; 34: 713 -17.
17. Bokoch GM,. Biology of the p21-activated kinases. Annu Rev Biochem 2003; 72: 743 -81.
18. Teo M, Manser E, Lim L,. Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem 1995; 270: 26690 -7.
19. Manser E, Chong C, Zhao ZS, Leung T, Michael G, Hall C, Lim L,. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J Biol Chem 1995; 270: 25070 -8.
20. Rennefahrt UE, Deacon SW, Parker SA, Devarajan K, Beeser A, Chernoff J, Knapp S, Turk BE, Peterson JR,. Specificity profiling of Pak kinases allows identification of novel phophorylation sites. J Biol Chem 2007; 282: 15667 -78.
21. Kumar R, Gururaj AE, Barnes CJ,. p21-activated kinases in cancer. Nat Rev Cancer 2006; 6: 459 -71.
22. Coniglio SJ, Zavarella S, Symons MH,. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol 2008; 28: 4162 -72.
23. Steinberg BM, Abramson AL, Meade RP,. Culture of human laryngeal papilloma cells in vitro. Otolaryngol Head Neck Surg 1982; 90: 728 -35.
24. Auborn KJ, Fan S, Rosen EM, Goodwin L, Chandraskaren A, Williams DE, Chen D, Carter TH,. Indole-3-carbinol is a negative regulator of estrogen. J Nutr 2003; 133: 2470 -5.
25. Orr AW, Stockton R, Simmers MB, Sanders JM, Sarembock IJ, Blackman BR, Schwartz MA,. Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. J Cell Biol 2007; 176: 719 -27.
26. Stoler MH, Wolinsky SM, Whitbeck A, Broker TR, Chow LT,. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989; 172: 331 -40.
27. Zhao ZS, Manser E,. PAK and other Rho-associated kinases effectors with surprisingly diverse mechanisms of regulation. Biochem J 2005; 386 (Part 2): 201 -14.
28. Deacon SW, Beeser A, Fukui JA, Rennefahrt UE, Myers C, Chernoff J, Peterson JR,. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 2008; 15: 322 -31.
29. Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH,. Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem 2000; 275: 19693 -9.
30. Dadke D, Fryer BH, Golemis EA, Field J,. Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation. Cancer Res 2003; 63: 8837 -47.
31. Schmedtje JF, Jr, Ji YS, Liu WL, DuBois RN, Runge MS,. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601 -8.
32. Inoue H, Tanabe T,. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 1998; 244: 143 -8.
33. Medicherla S, Reddy M, Ying J, Navas TA, Li L, Nguyen AN, Kerr I, Hanjarappa N, Protter AA, Higgins LS,. p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse zenograft models of multiple myeloma. Anticancer Res 2008; 28: 3827 -33.
34. Hirokawa Y, Nakajima H, Hanemann CO, Kurtz A, Frahm S, Mautner V, Maruta H,. Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biol Ther 2005; 4: 379 -81.